{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T15:43:56Z","timestamp":1792424636418,"version":"4.5.0"},"reference-count":50,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2009,2,1]],"date-time":"2009-02-01T00:00:00Z","timestamp":1233446400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2009,2,1]],"date-time":"2009-02-01T00:00:00Z","timestamp":1233446400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["ajkd.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Kidney Diseases"],"published-print":{"date-parts":[[2009,2]]},"DOI":"10.1053\/j.ajkd.2008.09.021","type":"journal-article","created":{"date-parts":[[2008,12,25]],"date-time":"2008-12-25T04:40:43Z","timestamp":1230180043000},"page":"197-207","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":119,"title":["A Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy and Safety of Cinacalcet HCl in Participants With CKD Not Receiving Dialysis"],"prefix":"10.1053","volume":"53","clinical-trial-number":[{"clinical-trial-number":"nct00094484","registry":"10.18810\/clinical-trials-gov"}],"author":[{"given":"Michel","family":"Chonchol","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Locatelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanna E.","family":"Abboud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chaim","family":"Charytan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angel L.M.","family":"de Francisco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shivinder","family":"Jolly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Kaplan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon D.","family":"Roger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shyamal","family":"Sarkar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moetaz B.","family":"Albizem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T. Christian H.","family":"Mix","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yumi","family":"Kubo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geoffrey A.","family":"Block","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1053\/j.ajkd.2008.09.021_bib1","first-page":"F253","article-title":"The calcium-sensing receptor: A key factor in the pathogenesis of secondary hyperparathyroidism","volume":"288","author":"Rodriguez","year":"2005","journal-title":"Am J Physiol"},{"key":"10.1053\/j.ajkd.2008.09.021_bib2","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/S0272-6386(97)90330-9","article-title":"The importance of dietary calcium and phosphorous in the secondary hyperparathyroidism of patients with early renal failure","volume":"29","author":"Martinez","year":"1997","journal-title":"Am J Kidney Dis"},{"key":"10.1053\/j.ajkd.2008.09.021_bib3","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1038\/sj.ki.5002009","article-title":"Prevalence of abnormal serum vitamin D, PTH, calcium, and phosphorus in patients with chronic kidney disease: Results of the study to evaluate early kidney disease","volume":"71","author":"Levin","year":"2007","journal-title":"Kidney Int"},{"key":"10.1053\/j.ajkd.2008.09.021_bib4","doi-asserted-by":"crossref","first-page":"2208","DOI":"10.1097\/01.ASN.0000133041.27682.A2","article-title":"Mineral metabolism, mortality, and morbidity in maintenance hemodialysis","volume":"15","author":"Block","year":"2004","journal-title":"J Am Soc Nephrol"},{"issue":"suppl 2","key":"10.1053\/j.ajkd.2008.09.021_bib5","doi-asserted-by":"crossref","first-page":"S34","DOI":"10.1016\/S0272-6386(04)01103-5","article-title":"Magnitude and impact of abnormal mineral metabolism in hemodialysis patients in the Dialysis Outcomes and Practice Patterns Study (DOPPS)","volume":"44","author":"Young","year":"2004","journal-title":"Am J Kidney Dis"},{"key":"10.1053\/j.ajkd.2008.09.021_bib6","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1111\/j.1523-1755.2005.00185.x","article-title":"Predictors and consequences of altered mineral metabolism: The Dialysis Outcomes and Practice Patterns Study","volume":"67","author":"Young","year":"2005","journal-title":"Kidney Int"},{"key":"10.1053\/j.ajkd.2008.09.021_bib7","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1056\/NEJM200005183422003","article-title":"Coronary-artery calcification in young adults with end-stage renal disease who are undergoing dialysis","volume":"342","author":"Goodman","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1053\/j.ajkd.2008.09.021_bib8","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1038\/sj.ki.5002028","article-title":"Uremia-related vascular calcification: More than apatite deposition","volume":"71","author":"Verberckmoes","year":"2007","journal-title":"Kidney Int"},{"key":"10.1053\/j.ajkd.2008.09.021_bib9","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1093\/ndt\/9.5.517","article-title":"Adynamic bone disease with negative aluminium staining in predialysis patients: Prevalence and evolution after maintenance dialysis","volume":"9","author":"Hernandez","year":"1994","journal-title":"Nephrol Dial Transplant"},{"key":"10.1053\/j.ajkd.2008.09.021_bib10","doi-asserted-by":"crossref","first-page":"2094","DOI":"10.1359\/jbmr.2002.17.12.2094","article-title":"Pathophysiology and recent advances in the management of renal osteodystrophy","volume":"17","author":"Elder","year":"2002","journal-title":"J Bone Miner Res"},{"key":"10.1053\/j.ajkd.2008.09.021_bib11","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1093\/ndt\/gfg116","article-title":"Spectrum of renal bone disease in end-stage renal failure patients not yet on dialysis","volume":"18","author":"Spasovski","year":"2003","journal-title":"Nephrol Dial Transplant"},{"key":"10.1053\/j.ajkd.2008.09.021_bib12","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1038\/ki.1995.201","article-title":"Bone disease in predialysis, hemodialysis, and CAPD patients: Evidence of a better bone response to PTH","volume":"47","author":"Torres","year":"1995","journal-title":"Kidney Int"},{"key":"10.1053\/j.ajkd.2008.09.021_bib13","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1136\/bmj.310.6976.358","article-title":"Effect of alfacalcidol on natural course of renal bone disease in mild to moderate renal failure","volume":"310","author":"Hamdy","year":"1995","journal-title":"BMJ"},{"key":"10.1053\/j.ajkd.2008.09.021_bib14","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1038\/366575a0","article-title":"Cloning and characterization of an extracellular Ca(2+)-sensing receptor from bovine parathyroid","volume":"366","author":"Brown","year":"1993","journal-title":"Nature"},{"key":"10.1053\/j.ajkd.2008.09.021_bib15","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1681\/ASN.2005070679","article-title":"Increased parathyroid hormone gene expression in secondary hyperparathyroidism of experimental uremia is reversed by calcimimetics: Correlation with posttranslational modification of the trans acting factor AUF1","volume":"17","author":"Levi","year":"2006","journal-title":"J Am Soc Nephrol"},{"key":"10.1053\/j.ajkd.2008.09.021_bib16","first-page":"1489","article-title":"Direct in vivo comparison of calcium-regulated parathyroid hormone secretion in normal volunteers and patients with secondary hyperparathyroidism","volume":"76","author":"Ramirez","year":"1993","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1053\/j.ajkd.2008.09.021_bib17","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1124\/jpet.103.057273","article-title":"Pharmacodynamics of the type II calcimimetic compound cinacalcet HCl","volume":"308","author":"Nemeth","year":"2004","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1053\/j.ajkd.2008.09.021_bib18","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.1056\/NEJMoa031633","article-title":"Cinacalcet for secondary hyperparathyroidism in patients receiving hemodialysis","volume":"350","author":"Block","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1053\/j.ajkd.2008.09.021_bib19","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1681\/ASN.2004060512","article-title":"Cinacalcet HCl, an oral calcimimetic agent for the treatment of secondary hyperparathyroidism in hemodialysis and peritoneal dialysis: A randomized, double-blind, multicenter study","volume":"16","author":"Lindberg","year":"2005","journal-title":"J Am Soc Nephrol"},{"key":"10.1053\/j.ajkd.2008.09.021_bib20","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1053\/j.ajkd.2005.04.013","article-title":"Cinacalcet hydrochloride is an effective treatment for secondary hyperparathyroidism in patients with CKD not receiving dialysis","volume":"46","author":"Charytan","year":"2005","journal-title":"Am J Kidney Dis"},{"key":"10.1053\/j.ajkd.2008.09.021_bib21","doi-asserted-by":"crossref","first-page":"461","DOI":"10.7326\/0003-4819-130-6-199903160-00002","article-title":"A more accurate method to estimate glomerular filtration rate from serum creatinine: A new prediction equation","volume":"130","author":"Levey","year":"1999","journal-title":"Ann Intern Med"},{"key":"10.1053\/j.ajkd.2008.09.021_bib22","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1210\/jc.2004-0842","article-title":"Cinacalcet hydrochloride maintains long-term normocalcemia in patients with primary hyperparathyroidism","volume":"90","author":"Peacock","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1053\/j.ajkd.2008.09.021_bib23","doi-asserted-by":"crossref","first-page":"305","DOI":"10.2215\/CJN.00870805","article-title":"Cinacalcet hydrochloride (Sensipar) in hemodialysis patients on active vitamin D derivatives with controlled PTH and elevated calcium x phosphorus","volume":"1","author":"Chertow","year":"2006","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1053\/j.ajkd.2008.09.021_bib24","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1242\/jeb.184.1.89","article-title":"Calcium handling by the mammalian kidney","volume":"184","author":"Bindels","year":"1993","journal-title":"J Exp Biol"},{"key":"10.1053\/j.ajkd.2008.09.021_bib25","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1038\/ki.1988.237","article-title":"Renal 25-hydroxyvitamin D3-1-hydroxylase in patients with renal disease","volume":"34","author":"Satomura","year":"1988","journal-title":"Kidney Int"},{"key":"10.1053\/j.ajkd.2008.09.021_bib26","doi-asserted-by":"crossref","first-page":"1858","DOI":"10.1038\/sj.ki.5001868","article-title":"Mortality risk among hemodialysis patients receiving different vitamin D analogs","volume":"70","author":"Tentori","year":"2006","journal-title":"Kidney Int"},{"key":"10.1053\/j.ajkd.2008.09.021_bib27","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1146\/annurev.nutr.25.050304.092642","article-title":"Regulation of phosphorus homeostasis by the type IIa Na\/phosphate cotransporter","volume":"25","author":"Tenenhouse","year":"2005","journal-title":"Annu Rev Nutr"},{"key":"10.1053\/j.ajkd.2008.09.021_bib28","first-page":"F157","article-title":"Vitamin D","volume":"277","author":"Brown","year":"1999","journal-title":"Am J Physiol"},{"key":"10.1053\/j.ajkd.2008.09.021_bib29","doi-asserted-by":"crossref","first-page":"4391","DOI":"10.1210\/endo.139.10.6262","article-title":"Normalization of mineral ion homeostasis by dietary means prevents hyperparathyroidism, rickets, and osteomalacia, but not alopecia in vitamin D receptor-ablated mice","volume":"139","author":"Li","year":"1998","journal-title":"Endocrinology"},{"issue":"suppl 3","key":"10.1053\/j.ajkd.2008.09.021_bib30","first-page":"S1","article-title":"K\/DOQI Clinical Practice Guidelines for Bone Metabolism and Disease in Chronic Kidney Disease","volume":"42","year":"2003","journal-title":"Am J Kidney Dis"},{"key":"10.1053\/j.ajkd.2008.09.021_bib31","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1681\/ASN.2004070602","article-title":"Serum phosphate levels and mortality risk among people with chronic kidney disease","volume":"16","author":"Kestenbaum","year":"2005","journal-title":"J Am Soc Nephrol"},{"key":"10.1053\/j.ajkd.2008.09.021_bib32","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1038\/sj.ki.5002002","article-title":"25-Hydroxyvitamin D, insulin resistance, and kidney function in the Third National Health and Nutrition Examination Survey","volume":"71","author":"Chonchol","year":"2007","journal-title":"Kidney Int"},{"key":"10.1053\/j.ajkd.2008.09.021_bib33","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1053\/j.ajkd.2005.02.029","article-title":"Prevalence of calcidiol deficiency in CKD: A cross-sectional study across latitudes in the United States","volume":"45","author":"LaClair","year":"2005","journal-title":"Am J Kidney Dis"},{"key":"10.1053\/j.ajkd.2008.09.021_bib34","first-page":"888","article-title":"Extrarenal expression of 25-hydroxyvitamin D(3)-1 alpha-hydroxylase","volume":"86","author":"Zehnder","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1053\/j.ajkd.2008.09.021_bib35","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1053\/j.ajkd.2007.04.010","article-title":"Changes in serum 25-hydroxyvitamin D and plasma intact PTH levels following treatment with ergocalciferol in patients with CKD","volume":"50","author":"Al-Aly","year":"2007","journal-title":"Am J Kidney Dis"},{"key":"10.1053\/j.ajkd.2008.09.021_bib36","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1159\/000098561","article-title":"Impact of ergocalciferol treatment of vitamin D deficiency on serum parathyroid hormone concentrations in chronic kidney disease","volume":"27","author":"Zisman","year":"2007","journal-title":"Am J Nephrol"},{"key":"10.1053\/j.ajkd.2008.09.021_bib37","doi-asserted-by":"crossref","first-page":"1788","DOI":"10.1681\/ASN.2004040275","article-title":"Calcium, phosphorus, parathyroid hormone, and cardiovascular disease in hemodialysis patients: The USRDS Waves 1, 3, and 4 Study","volume":"16","author":"Slinin","year":"2005","journal-title":"J Am Soc Nephrol"},{"key":"10.1053\/j.ajkd.2008.09.021_bib38","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1111\/j.1523-1755.2005.00596.x","article-title":"Effects of the calcimimetic cinacalcet HCl on cardiovascular disease, fracture, and health-related quality of life in secondary hyperparathyroidism","volume":"68","author":"Cunningham","year":"2005","journal-title":"Kidney Int"},{"key":"10.1053\/j.ajkd.2008.09.021_bib39","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1681\/ASN.2004070573","article-title":"Activated injectable vitamin D and hemodialysis survival: A historical cohort study","volume":"16","author":"Teng","year":"2005","journal-title":"J Am Soc Nephrol"},{"key":"10.1053\/j.ajkd.2008.09.021_bib40","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1093\/oxfordjournals.ndt.a027404","article-title":"Renal bone disease in 76 patients with varying degrees of predialysis chronic renal failure: A cross-sectional study","volume":"11","author":"Coen","year":"1996","journal-title":"Nephrol Dial Transplant"},{"key":"10.1053\/j.ajkd.2008.09.021_bib41","doi-asserted-by":"crossref","first-page":"2187","DOI":"10.1046\/j.1523-1755.2002.00372.x","article-title":"Advanced atherosclerosis in predialysis patients with chronic renal failure","volume":"61","author":"Shoji","year":"2002","journal-title":"Kidney Int"},{"key":"10.1053\/j.ajkd.2008.09.021_bib42","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1111\/j.1492-7535.2004.01104.x","article-title":"Coronary and aortic calcifications in patients new to dialysis","volume":"8","author":"Spiegel","year":"2004","journal-title":"Hemodial Int"},{"key":"10.1053\/j.ajkd.2008.09.021_bib43","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1046\/j.1523-1755.1999.00617.x","article-title":"Bone mineral density and biochemical markers of bone turnover in patients with predialysis chronic renal failure","volume":"56","author":"Rix","year":"1999","journal-title":"Kidney Int"},{"key":"10.1053\/j.ajkd.2008.09.021_bib44","doi-asserted-by":"crossref","first-page":"825","DOI":"10.2215\/CJN.02101205","article-title":"Association of disorders in mineral metabolism with progression of chronic kidney disease","volume":"1","author":"Schwarz","year":"2006","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1053\/j.ajkd.2008.09.021_bib45","doi-asserted-by":"crossref","first-page":"89","DOI":"10.2215\/CJN.01170905","article-title":"Predictors of early mortality among incident US hemodialysis patients in the Dialysis Outcomes and Practice Patterns Study (DOPPS)","volume":"2","author":"Bradbury","year":"2007","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1053\/j.ajkd.2008.09.021_bib46","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1111\/j.1523-1755.2005.67103.x","article-title":"Cinacalcet HCl attenuates parathyroid hyperplasia in a rat model of secondary hyperparathyroidism","volume":"67","author":"Colloton","year":"2005","journal-title":"Kidney Int"},{"key":"10.1053\/j.ajkd.2008.09.021_bib47","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1681\/ASN.2005040342","article-title":"Calcimimetic R-568 decreases extraosseous calcifications in uremic rats treated with calcitriol","volume":"17","author":"Lopez","year":"2006","journal-title":"J Am Soc Nephrol"},{"key":"10.1053\/j.ajkd.2008.09.021_bib48","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1053\/j.ajkd.2005.10.007","article-title":"Paricalcitol capsule for the treatment of secondary hyperparathyroidism in stages 3 and 4 CKD","volume":"47","author":"Coyne","year":"2006","journal-title":"Am J Kidney Dis"},{"key":"10.1053\/j.ajkd.2008.09.021_bib49","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1159\/000092033","article-title":"A comparison of dosing regimens of paricalcitol capsule for the treatment of secondary hyperparathyroidism in CKD stages 3 and 4","volume":"26","author":"Abboud","year":"2006","journal-title":"Am J Nephrol"},{"key":"10.1053\/j.ajkd.2008.09.021_bib50","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1053\/j.ajkd.2004.01.012","article-title":"Doxercalciferol safely suppresses PTH levels in patients with secondary hyperparathyroidism associated with chronic kidney disease stages 3 and 4","volume":"43","author":"Coburn","year":"2004","journal-title":"Am J Kidney Dis"}],"container-title":["American Journal of Kidney Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272638608015692?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272638608015692?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T01:51:14Z","timestamp":1759456274000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0272638608015692"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,2]]},"references-count":50,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2009,2]]}},"alternative-id":["S0272638608015692"],"URL":"https:\/\/doi.org\/10.1053\/j.ajkd.2008.09.021","relation":{},"ISSN":["0272-6386"],"issn-type":[{"value":"0272-6386","type":"print"}],"subject":[],"published":{"date-parts":[[2009,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy and Safety of Cinacalcet HCl in Participants With CKD Not Receiving Dialysis","name":"articletitle","label":"Article Title"},{"value":"American Journal of Kidney Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.ajkd.2008.09.021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1053\/j.ajkd.2008.12.002","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2009 National Kidney Foundation, Inc. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}